HEXPOL Past Earnings Performance
Past criteria checks 2/6
HEXPOL has been growing earnings at an average annual rate of 13.1%, while the Chemicals industry saw earnings declining at 3.8% annually. Revenues have been growing at an average rate of 10.8% per year. HEXPOL's return on equity is 16.3%, and it has net margins of 11.5%.
Key information
13.1%
Earnings growth rate
13.1%
EPS growth rate
Chemicals Industry Growth | 4.3% |
Revenue growth rate | 10.8% |
Return on equity | 16.3% |
Net Margin | 11.5% |
Next Earnings Update | 28 Jan 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How HEXPOL makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 20,611 | 2,374 | 1,026 | 152 |
30 Jun 24 | 21,095 | 2,485 | 1,057 | 152 |
31 Mar 24 | 21,368 | 2,510 | 1,071 | 152 |
31 Dec 23 | 22,046 | 2,524 | 1,096 | 152 |
30 Sep 23 | 22,673 | 2,641 | 1,084 | 137 |
30 Jun 23 | 23,133 | 2,586 | 1,052 | 137 |
31 Mar 23 | 23,060 | 2,551 | 1,017 | 137 |
31 Dec 22 | 22,243 | 2,483 | 946 | 137 |
30 Sep 22 | 20,833 | 2,305 | 915 | 111 |
30 Jun 22 | 19,020 | 2,531 | 818 | 111 |
31 Mar 22 | 17,368 | 2,424 | 723 | 111 |
31 Dec 21 | 16,005 | 2,358 | 698 | 111 |
30 Sep 21 | 15,322 | 2,368 | 741 | 97 |
30 Jun 21 | 14,542 | 1,953 | 763 | 97 |
31 Mar 21 | 13,066 | 1,538 | 804 | 97 |
31 Dec 20 | 13,424 | 1,409 | 904 | 97 |
30 Sep 20 | 13,796 | 1,289 | 971 | 105 |
30 Jun 20 | 14,712 | 1,218 | 1,030 | 105 |
31 Mar 20 | 15,871 | 1,509 | 1,018 | 105 |
31 Dec 19 | 15,508 | 1,542 | 942 | 105 |
30 Sep 19 | 15,291 | 1,611 | 825 | 99 |
30 Jun 19 | 14,490 | 1,660 | 755 | 99 |
31 Mar 19 | 14,266 | 1,673 | 729 | 99 |
31 Dec 18 | 13,770 | 1,646 | 686 | 99 |
30 Sep 18 | 13,139 | 1,690 | 647 | 91 |
30 Jun 18 | 12,632 | 1,619 | 614 | 91 |
31 Mar 18 | 12,401 | 1,559 | 608 | 91 |
31 Dec 17 | 12,230 | 1,527 | 592 | 91 |
30 Sep 17 | 12,057 | 1,452 | 607 | 82 |
30 Jun 17 | 11,863 | 1,458 | 607 | 82 |
31 Mar 17 | 11,260 | 1,421 | 591 | 82 |
31 Dec 16 | 10,879 | 1,397 | 585 | 82 |
30 Sep 16 | 10,722 | 1,349 | 588 | 78 |
30 Jun 16 | 10,752 | 1,368 | 568 | 78 |
31 Mar 16 | 11,035 | 1,396 | 556 | 78 |
31 Dec 15 | 11,229 | 1,393 | 543 | 78 |
30 Sep 15 | 10,964 | 1,315 | 565 | 64 |
30 Jun 15 | 10,504 | 1,237 | 542 | 64 |
31 Mar 15 | 9,739 | 1,138 | 497 | 64 |
31 Dec 14 | 8,919 | 1,048 | 448 | 64 |
30 Sep 14 | 8,511 | 1,054 | 385 | 55 |
30 Jun 14 | 8,238 | 1,006 | 376 | 55 |
31 Mar 14 | 8,153 | 976 | 370 | 55 |
31 Dec 13 | 8,036 | 930 | 378 | 55 |
Quality Earnings: 0R7O has high quality earnings.
Growing Profit Margin: 0R7O's current net profit margins (11.5%) are lower than last year (11.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 0R7O's earnings have grown by 13.1% per year over the past 5 years.
Accelerating Growth: 0R7O's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 0R7O had negative earnings growth (-10.1%) over the past year, making it difficult to compare to the Chemicals industry average (-36.8%).
Return on Equity
High ROE: 0R7O's Return on Equity (16.3%) is considered low.